ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2151

Synergistic Effect of Combining BioniCare® in an Unloading Brace for Osteoarthritis of the Knee

Thomas Zizic1, David S. Hungerford2, Edmund J. MacLaughlin3, Craig Mines4, Shaili Deveshwar5, Theresa Lawrence Ford6, Cynthia Elliott6, John R. Principe7, Jack S. Tuber8 and Joy Schechtman9, 1Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Ortho Surgery, Johns Hopkins University, Baltimore, MD, 3The Johns Hopkins University School of Medicine, Cambridge, MD, 4East Side OrthoCare, Snellville, GA, 5Sports Medicine and Orthopedic Center, Greensboro, NC, 6North Georgia Rheumatology, Lawrenceville, GA, 7WellBeingMD, Palos Heights, IL, 8The Johns Hopkins University, Baltimore, Maryland, Baltimore, MD, 9SunValley Arthritis Center, Peoria, AZ

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Knee, osteoarthritis and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects II: Symptoms and Therapeutics in Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: The purpose of this study was to see if incorporating the BioniCare device into an unloading brace would produce more rapid improvement, greater compliance and therefore greater effectiveness  

Methods: 289  patients who were treated with BioniCare alone served as historical controls and were compared with 225 patients treated with BioniCare combined with VQ’s OActive unloading brace. A generalized linear model repeated measures analysis of change from baseline was performed, with sex, age, treatment (BioniCare in knee OActive unloading brace versus BioniCare alone), cumulative device use at each month of follow-up (1, 3, 6 and 12 months), and baseline score as predictors of the model.

Results: It was demonstrated that BioniCare combined with the OActive unloading brace was superior to BioniCare alone. Except for Sleep Pain, and Physicians Global Assessment which trended toward statistical significance, there was statistically significant superiority of BioniCare treatment combined with an unloading brace as compared to BioniCare alone. (Table I)  With the exception of the one month evaluation of pain while sleeping at night, all seven outcome measures were superior with BioniCare combined in the OActive unloading brace as compared to BioniCare alone at 1,3,6 and 12 months of treatment. After three months of treatment both groups had a moderate effect size in all outcome parameters. As can be seen in the illustrative figures, the patient global assessment, patient pain on walking up and down stairs, and the physician global assessment had a large effect size (>1.0) at one year in the BioniCare combined with the unloading brace group. (Figures 1, 2) In the combined group, the effect size approached 1.0 with pain on walking on a flat surface (figure 2).

Conclusion: There is an additive benefit of combining an unloading brace with BioniCare device treatment and the advantage of this combination continued throughout the study and was apparent  even after one year of treatment.

 

 

 

 

 

Efficacy End-point

Estimate Treatment Difference

Std Err

Chi-Square Test

p-value

48 hr. OA Pain

0.2060

0.0527

15.28

<.0001

MD Global Assessment

0.0927

0.0532

3.04

0.0814

OA Pain

0.1864

0.0516

13.07

0.0003

PT Global Assessment

0.2066

0.0543

14.48

0.0001

Sleep Pain

0.0295

0.0553

0.29

0.5933

Up/Down Stairs

0.2684

0.0582

21.29

<.0001

Walking Pain

0.2119

0.0536

15.65

<.0001

NOTE: Treatment effect as estimated from a generalized linear model of repeated measures

Treatment of osteoarthritis of the knee with BioniCare in an OActive unloading brace is significantly superior to BioniCare alone.

BioniCareVsBioniCarewithOActive_MD_PTGlobal

FIG 1: Change From Baseline Time Physician and Patient Global

 

 

 

BioniCareVsBioniCarewithOActive_Walking_Stair Pain

FIG 2: Change From Baseline Time Walking Pain and Stair Pain


Disclosure:

T. Zizic,

VQ OrthoCare,

5;

D. S. Hungerford,
None;

E. J. MacLaughlin,
None;

C. Mines,
None;

S. Deveshwar,
None;

T. L. Ford,
None;

C. Elliott,
None;

J. R. Principe,
None;

J. S. Tuber,
None;

J. Schechtman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synergistic-effect-of-combining-bionicare-in-an-unloading-brace-for-osteoarthritis-of-the-knee/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology